Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Basarab

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|July 10, 2015
Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)Gregory S Basarab, Peter Doig, Vincent Galullo, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative PathogensDavid C McKinney, Gregory S Basarab, Alexis I Cocozaki, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Dose-fractionation studies of a <i>Plasmodium</i> phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malariaLiezl Gibhard, Mathew Njoroge, Mwila Mulubwa, et al.
Journal of Medicinal Chemistry|June 12, 2018
Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of MalariaNishanth Kandepedu, Diego Gonzàlez Cabrera, Srinivas Eedubilli, et al.
The Journal of Biological Chemistry|July 8, 2015
Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914Gunther Kern, Tiffany Palmer, David E Ehmann, et al.
Macromolecular Bioscience|March 31, 2023
A Water-Soluble Polymer-Lumefantrine Conjugate for the Intravenous Treatment of Severe MalariaWilliam M R Matshe, Lesego L Tshweu, Sindisiwe Mvango, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteriaMichael D Huband, Patricia A Bradford, Linda G Otterson, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
A Novel Class of Orally Bioavailable Phenylglycine-Benzoxaborole Conjugates with Antimalarial Activity and Potentially Novel Mechanism of ActionMokhitli Morake, Dale Taylor, Dina Coertzen, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Journal of Medicinal Chemistry|May 2, 2022
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis ActivityPreshendren Govender, Rudolf Müller, Kawaljit Singh, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|July 10, 2015
Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)Gregory S Basarab, Peter Doig, Vincent Galullo, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative PathogensDavid C McKinney, Gregory S Basarab, Alexis I Cocozaki, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Dose-fractionation studies of a <i>Plasmodium</i> phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malariaLiezl Gibhard, Mathew Njoroge, Mwila Mulubwa, et al.
Journal of Medicinal Chemistry|June 12, 2018
Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of MalariaNishanth Kandepedu, Diego Gonzàlez Cabrera, Srinivas Eedubilli, et al.
The Journal of Biological Chemistry|July 8, 2015
Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914Gunther Kern, Tiffany Palmer, David E Ehmann, et al.
Macromolecular Bioscience|March 31, 2023
A Water-Soluble Polymer-Lumefantrine Conjugate for the Intravenous Treatment of Severe MalariaWilliam M R Matshe, Lesego L Tshweu, Sindisiwe Mvango, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteriaMichael D Huband, Patricia A Bradford, Linda G Otterson, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
A Novel Class of Orally Bioavailable Phenylglycine-Benzoxaborole Conjugates with Antimalarial Activity and Potentially Novel Mechanism of ActionMokhitli Morake, Dale Taylor, Dina Coertzen, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Journal of Medicinal Chemistry|May 2, 2022
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis ActivityPreshendren Govender, Rudolf Müller, Kawaljit Singh, et al.
Pageof 5